Cancer Immunotherapy Winter School – Travel Award Recipients

Abdul Rafeh Naqash, MD


National Cancer Institutes

Abdul Rafeh Naqash, MD, received his medical degree at Government Medical College Srinagar, Kashmir. He completed his Internal medicine residency training at the University of Buffalo/Catholic Health and his sub-specialty clinical training in Hematology/Oncology at East Carolina University, Greenville, NC. Currently, Dr. Naqash is pursuing an Investigational Cancer Therapeutics fellowship at the National Cancer Institute, Bethesda with a focus on developing phase I/II trials involving novel combinations that include targeted agents, chemotherapies and immunotherapies for patients with advanced solid tumors.  Dr. Naqash’s long-term interests revolve around identifying biomarkers of response or resistance to immune checkpoint therapies and evaluating the mechanistic aspects of immune-related adverse events (irAEs) and their clinical outcomes. Dr. Naqash is also a member of Sparkathon class of 2018, a SITC driven young investigator collaborative network working on developing a trial with correlative studies to evaluate the optimal duration of immune checkpoint therapy in melanoma.